Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 88
Selected: 0
NCT IDTitle
NCT00541905Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
NCT01910896Effectiveness and Safety Study of Overnight Intensive Patch in Scars
NCT07018700A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
NCT00972127Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT03986424Local Study of Akatinol Memantine in VaD in Russia
NCT00515944Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
NCT00955799Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT01893411Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
NCT00770211IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT01603459Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT00432666IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb
NCT01515371Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
NCT03806933Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT00649220Memantine and Antipsychotics Use
NCT04766723A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm
NCT00739635Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT01999894Open-label Study of Safety and Tolerability of Memantine in Children With Autism
NCT00465738IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
NCT06995287Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
NCT03119948Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
NCT00827008Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT00712283Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers
NCT01464307Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT05943860Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss
NCT01686061Blepharospasm Patient Survey for Patients With Blepharospasm
NCT00541723Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles
NCT01261741Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
NCT00936026Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane
NCT00872898Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
NCT00694148Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT04594213Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT01900041A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
NCT05623111Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities
NCT05884528Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
NCT00804271Memantine and Validation of a New Alzheimer's Disease Scale
NCT00777803NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
NCT00978614Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects
NCT00430963IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT01112371Contractubex Treatment in Scars After Abdominal Caesarean Section
NCT01392300Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT02212119Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness
NCT02270736Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT00512135Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
NCT04792398Bruxism Xeomin® Intervention Trial
NCT02207946Botulinum Toxin A to Treat Arm Tremor
NCT00772980Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
NCT00406367IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
NCT01405482Botulinum Toxin Injections for Thoracic Outlet Syndrome
NCT07018713A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
NCT01305187Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3